Post-TURP Bleeding and Anticoagulation Dilemma
A 72-year-old man with a history of atrial fibrillation on apixaban, hypertension, and a 60-pack-year smoking history undergoes bipolar TURP for benign prostatic obstruction. His preoperative IPSS is 24 and prostate volume 60 mL. Apixaban was held 48 hours before surgery. Intraoperatively, bleeding is moderate, and a catheter is placed with 30 mL balloon and continuous bladder irrigation. Six hours postoperatively, the urine is frank bloody with clots, and the patient is passing small clots per urethra. He is hemodynamically stable, Hb 10.2 g/dL (preop 13.5), platelets 210,000, INR 1.1, and creatinine 1.3 mg/dL. The patient is anxious about restarting anticoagulation. The urology team must decide on management of bleeding and resumption of anticoagulation.
1. What is your immediate management of the post-TURP bleeding, and what factors determine the need for re-exploration or bladder irrigation?
Read the worked answer
Immediate management includes: 1) Ensure catheter patency: manually irrigate to remove clots, increase continuous bladder irrigation rate, and consider a three-way catheter with larger lumen. 2) Correct any coagulopathy: check CBC, coagulation profile, and consider tranexamic acid. 3) Monitor hemodynamics and urine output. 4) If bleeding persists despite irrigation, consider cystoscopy and clot evacuation under anesthesia, and fulguration of bleeding points. Re-exploration is indicated if there is hemodynamic instability, inability to maintain catheter patency, or persistent significant bleeding despite conservative measures. Factors determining need for re-exploration: rate of bleeding (Hb drop), clot retention, bladder distension, and failure of irrigation to clear urine. In this patient, initial conservative management with irrigation and monitoring is appropriate as he is stable, but if clots persist or Hb drops further, cystoscopy and fulguration should be performed.
2. When and how should apixaban be restarted, considering his bleeding risk and stroke risk?
Read the worked answer
The decision to restart anticoagulation balances bleeding risk (post-TURP) and stroke risk (CHA2DS2-VASc score). His CHA2DS2-VASc score: age 72 (2 points), hypertension (1), no diabetes, no stroke, no vascular disease, no heart failure, male (0) = 3 points, indicating moderate-high stroke risk. Apixaban was held 48h preop. After TURP, restarting anticoagulation typically occurs once hemostasis is secure, usually 48-72 hours postoperatively, depending on bleeding. In this patient with ongoing bleeding, it is prudent to delay restarting apixaban until bleeding is controlled and urine is clear, usually within 48-72 hours. Bridging with heparin is not routinely recommended for apixaban due to its short half-life, but if bleeding persists beyond 72h, consider bridging with LMWH while monitoring. Multidisciplinary discussion with cardiology is advised. Once restarted, apixaban can be resumed at the usual dose (5 mg BID) if creatinine clearance is adequate. Monitor for bleeding.